Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

Mary Hines

Dabrafenib: promising results for melanoma

The BREAK-2 phase II trial showed that dabrafenib 150mg twice daily had rapid onset of action, high response rates and prolonged progression-free survival

- PMLiVE

Sir Tom Blundell to remain as chair of UK’s biotech research council

Reappointed to government role to support research

- PMLiVE

How to Master Multichannel Marketing in Pharma

Learn how to optimise your multichannel marketing for increased profitability and improved customer engagement.

Blue Latitude Health

- PMLiVE

Sanofi gets EMA backing for multi-disease vaccine in children

Hexyon-Hexacima 6-in-1 paediatric vaccine recommended for approval in Europe

Growing pains at WebMD

Health information site increases traffic but sees falling revenues in 2012

- PMLiVE

Novartis gives Vasella honorary role as payout row continues

Named honorary chairman chairman at Swiss pharma firm after stepping down as chairman

- PMLiVE

Second approval in US for Bayer-Onyx’ Stivarga

FDA clears drug to treat patients with gastrointestinal stromal tumours

- PMLiVE

EMA application fees set for slower rise in 2013

European regulator expects rate to increase by 2.6 per cent

- PMLiVE

Takeda-Affymax recall Omontys in US after deaths

Severe allergic reactions reported in kidney disease patients taking anaemia drug

- PMLiVE

Former Glaxo CEO Ernest Mario to chair Chimerix

Pharma veteran has previously also served as CEO of Alza and Reliant

- PMLiVE

Evidence: The unmet need

Only through change can the pharma industry align its products with the unmet needs of payers

- PMLiVE

Service sector salary survey: the results

Following last month's analysis of pharma salaries, we bring you the results from those working on the service side of the healthcare industry

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links